Text Size
1855 studies found for:    vaccination

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination
Condition: Cystic Fibrosis With Gastrointestinal Manifestation
Intervention: Biological: influenza vaccination
2 Completed Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules
Condition: Meningococcal Infections
Interventions: Biological: rMenB and concomitantly routine infant vaccinations;   Biological: rMenB and routine infant vaccinations;   Biological: Routine infant vaccines
3 Completed Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
Condition: Influenza
Interventions: Biological: Vaccination with Fluval P and Fluval AB influenza vaccines;   Biological: Vaccination with Fluval P monovalent influenza vaccine
4 Recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination
5 Completed Influenza Vaccination in the Emergency Department
Condition: Influenza
Interventions: Drug: Influenza Vaccination;   Behavioral: Education and referral
6 Completed Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Interventions: Biological: rMenB+OMV NZ with routine vaccinations;   Biological: rMenB+OMV NZ;   Biological: two doses of rMenB+OMV NZ
7 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
8 Completed T Cell Vaccination in Patients With Progressive Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides);   Biological: T cell vaccination
9 Recruiting Polio NID and Routine EPI Integration Trial Pakistan
Condition: Polio
Interventions: Behavioral: Vaccine promotion messages;   Other: Vaccination Verification.;   Other: Distribution of Plastic Pouches to retain vaccination card
10 Completed Efficacy Study of T Cell Vaccination in HIV Infection
Condition: HIV Infections
Intervention: Biological: T cell vaccination
11 Completed
Has Results 		Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
Condition: HIV Infections
Interventions: Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccination
12 Recruiting Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Conditions: HPV16+;   Cervical Intraepithelial Neoplasia (CIN 2/3)
Interventions: Biological: DNA vaccination;   Device: Gene gun vaccine;   Biological: intramuscular vaccination;   Biological: intra-lesional vaccine administration;   Procedure: therapeutic resection of the lesion
13 Active, not recruiting From Innovation to Solutions: Childhood Influenza Vaccination Planning
Condition: Influenza Vaccination Rates
Intervention: Other: 4 Pillars Toolkit for increasing childhood influenza vaccination rates
14 Active, not recruiting Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP
Condition: Malaria
Interventions: Biological: Vaccination Schedule One;   Biological: Vaccination Schedule Two;   Biological: Vaccination Schedule Three;   Biological: Vaccination Schedule Four;   Biological: Vaccination Schedule Five;   Biological: Vaccination Schedule Six;   Biological: Vaccination Schedule Seven
15 Recruiting Teen VaxScene Educational Vaccination Study
Condition: Adolescent Vaccination Status
Interventions: Behavioral: Vaccination Email Reminder: Study 1 and 2;   Behavioral: Tailored Educational Messaging: Study 2
16 Completed Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules
Condition: Hepatitis B
Intervention: Biological: Vaccination to prevent hepatitis B virus infection
17 Completed Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination
Condition: Tick-borne Encephalitis
Intervention: Biological: TBE vaccination and influenza vaccination
18 Completed Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers
Condition: Meningococcal Disease
Interventions: Biological: 1a - rMenB+OMV NZ and routine infant vaccinations;   Biological: 1b - rMenB+OMV NZ and routine infant vaccinations;   Biological: 2a - Routine infant vaccinations and rMenB+OMV NZ;   Biological: 2b - rMenB+OMV NZ and routine infant vaccinations;   Biological: 3a - rMenB+OMV NZ and routine infant vaccinations;   Biological: 3b - 1 dose of rMenB+OMV NZ plus routine infant vaccinations;   Biological: 4a- rMenB+OMV NZ and routine infant vaccinations;   Biological: 4b - rMenB+OMV NZ and routine infant vaccinations
19 Completed Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Biological: recombinant human Growth Hormone;   Biological: Vaccination;   Drug: HAART
20 Completed Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
Condition: Influenza
Intervention: Biological: School-based influenza vaccination program
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years